Phase 3 Validation of Biomarkers for the Early Detection of ER+ Breast Cancer
- Abbreviated Name
- Phase 3 Validation of Biomarkers for the Early Detection of ER+ Breast Cancer
- Lead Investigator
- Li, Christopher — Fred Hutchinson Cancer Center
- Coordinating Investigator
- No coordinating investigator
- Involved Investigators
Abstact
No abstract availalbe.
Aims
No aims available.
Analytic Method
No analytic method available.
Publications
- No publications available at this time for this protocol.
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
- Start Date
- Sep 1 2023
- Estimated Finish Date
- Aug 31 2028
- Protocol ID
- 528
- Protocol Type
- Single
- Field of Research
- UNKNOWN
- Collaborative Group
- Breast and Gynecologic Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of breast